Keros Therapeutics, Inc.

Keros Therapeutics, Inc.

08 Jan 2019
$23,000,000
Venture capital (Series B)
Pontifax, Arkin Bio Ventures, Partners and Innovation Fund, +2

Keros Therapeutics nets $23 mln Series B

PE Hub
18 Aug 2016
$3,670,000
Venture capital

SEC FORM D/A

sec